Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
✍ Scribed by P. Roggenkämper; W. H. Jost; K. Bihari; G. Comes; S. Grafe; for the NT 201 Blepharospasm Study Team
- Publisher
- Springer
- Year
- 2005
- Tongue
- English
- Weight
- 114 KB
- Volume
- 113
- Category
- Article
- ISSN
- 1435-1463
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Efficacy of botulinum toxin type B (BoNT B) for the treatment of type A‐resistant (AR) and non‐A‐resistant (NAR) cervical dystonia (CD) has been demonstrated in several single injection studies. There is little data available on long‐term therapy with repeated injection sessions and it
## Abstract Sialorrhea (drooling) is a common symptom of Parkinson's disease (PD) that can significantly impair a patient's health and quality of life. Fifty‐four PD subjects with troublesome sialorrhea were enrolled using a multicenter, randomized, double‐blind, sequential‐dose escalation design i